Aibili Logo Association for Innovation and Biomedical Research on Light

AIBILI - Association for Innovation and Biomedical Research on Light and Image is a Research Technology Organisation in the health area dedicated to the development and clinical research of new products for medical therapy and diagnostic imaging.

It is a private non-profit organisation, founded in 1989, established to support translational research and technology transfer in the health area.

AIBILI is certified by ISO 9001 since 2004. It is certified for the following activities: performance of clinical studies; planning, coordination, monitoring of clinical research activities; health technology assessment; grading of eye exams; research and development in new technologies for medicine in the areas of imaging, optics and photobiology; preclinical studies of new molecules with potential medical use; and data centre activities.

AIBILI has the ECRIN Data Centre Certification, meeting the ECRIN requirements for IT and Data Management within clinical trials.

Clinical trials are performed in accordance with ICH Guidelines for Good Clinical Practice (GCP), European and national applicable legislations and regulations.


22 Sep 2017
Enquiry on Notification of Adverse Drug Events / Inquérito sobre notificação de reações adversas a medicamentos

Please see info attached. / Por favor verifique circular em anexo.

22 Sep 2017
Symposium on Drug Market Access

AIBILI organized a symposium on September 22, 2017 on Drug Market Access. Please download here the programme.

28 Jul 2017
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 4, Nº 2 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 4, Nº 2

Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines.

Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde.


Copyright © 2017 AIBILI   -   Contact Us   -   Site Map   -   Webdesign Glitz Design   -   Programming Bizview